Data / Form D filings / CorriXR Therapeutics, Inc.
CorriXR Therapeutics, Inc.: Form D filings
CorriXR Therapeutics, Inc., a biotechnology company in Newark, DE, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on January 29, 2024, reports $6.5 million sold of a $8 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 550 S. College Avenue, Suite 107, Newark, DE, 19713
- Phone
- (302) 623-5305
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1938281
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | Amendment | $8,028,610 | $6,525,179 | $1,503,431 | 4 | Jun 30, 2022 | sec.gov |
| Jul 15, 2022 | New notice | $8,028,610 | $2,499,998 | $5,528,612 | 1 | Jun 30, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Carper | Director | |
| Jon Brilliant | Executive Officer | |
| Deborah Moorad | Executive Officer, Director | |
| Janice Nevin | Director | |
| Stella Vnook | Director | |
| Eric Kmiec | Executive Officer, Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Jan 29, 2024 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CorriXR Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.